The Journal of Nanobiotechnology Article of the Year Award recognises an outstanding research publication in the journal, selected by the editors from amongst the most highly cited and downloaded research downloaded research published during the previous year.
Articles of the Year 2022
Chen, Z., Han, S., Sanny, A. et al. 3D hanging spheroid plate for high-throughput CAR T cell cytotoxicity assay. J Nanobiotechnol 20, 30 (2022)
Yu, Z., Guo, J., Liu, Y. et al. Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma. J Nanobiotechnol 20, 9 (2022)
Li, K., Yan, G., Huang, H. et al. Anti-inflammatory and immunomodulatory effects of the extracellular vesicles derived from human umbilical cord mesenchymal stem cells on osteoarthritis via M2 macrophages. J Nanobiotechnol 20, 38 (2022)
Li, F., Wu, J., Li, D. et al. Engineering stem cells to produce exosomes with enhanced bone regeneration effects: an alternative strategy for gene therapy. J Nanobiotechnol 20, 135 (2022)
Wang, D., Chen, L., Li, C. et al. CRISPR/Cas9 delivery by NIR-responsive biomimetic nanoparticles for targeted HBV therapy. J Nanobiotechnol 20, 27 (2022)
Articles of the Year 2021
Zhao, Q., Sun, X., Wu, B. et al. Construction of homologous cancer cell membrane camouflage in a nano-drug delivery system for the treatment of lymphoma. J Nanobiotechnol 19, 8 (2021).
Bao, S., Hu, T., Liu, J. et al. Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer. J Nanobiotechnol 19, 22 (2021).
Fang, H., Gai, Y., Wang, S. et al. Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer. J Nanobiotechnol 19, 81 (2021).
Hu, Y., Tao, R., Chen, L. et al. Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis. J Nanobiotechnol 19, 150 (2021).
Article of the Year 2020
Liang, G., Zhu, Y., Ali, D.J. et al. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J Nanobiotechnol 18, 10 (2020).
Article of the Year 2019
Sancho-Albero, M., Navascués, N., Mendoza, G. et al. Exosome origin determines cell targeting and the transfer of therapeutic nanoparticles towards target cells. J Nanobiotechnol 17, 16 (2019).